Literature DB >> 8300449

Role of cell-binding in the antibacterial mechanism of lactoferricin B.

W R Bellamy1, H Wakabayashi, M Takase, K Kawase, S Shimamura, M Tomita.   

Abstract

The antibacterial cell-binding properties of lactoferricin B, a potent bactericidal peptide derived from bovine lactoferrin, were investigated for the first time. To facilitate measurements of binding the peptide was radiolabelled by reduction and treatment with iodo-[1-14C]acetamide. 14C-lactoferricin B bound rapidly to the surface of Escherichia coli and Bacillus subtilis. The rate of binding was consistent with the rapid rate of killing caused by this peptide. The extent of binding was reduced in the presence of Mg2+ or Ca2+ ions which act to reduce its antimicrobial effectiveness. The optimal pH for binding was strain-dependent and the killing effect was maximal near the optimal pH for cell binding with each strain tested. These observations indicate that direct interaction of lactoferricin B with the cell surface is necessary for its lethal effect. The number of peptide molecules bound (> 10(6) per cell) was more than would be expected for binding to specific protein receptors. Lactoferricin B inhibited bacterial uptake of 3H-proline with effectiveness similar to polymyxin B, a known membrane-disruptive agent. The cell-binding event appears to lead to a disruption of normal permeability functions of the cytoplasmic membrane.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8300449

Source DB:  PubMed          Journal:  J Appl Bacteriol        ISSN: 0021-8847


  12 in total

1.  N-Acylated and D enantiomer derivatives of a nonamer core peptide of lactoferricin B showing improved antimicrobial activity.

Authors:  H Wakabayashi; H Matsumoto; K Hashimoto; S Teraguchi; M Takase; H Hayasawa
Journal:  Antimicrob Agents Chemother       Date:  1999-05       Impact factor: 5.191

2.  Giardicidal activity of lactoferrin and N-terminal peptides.

Authors:  J M Turchany; S B Aley; F D Gillin
Journal:  Infect Immun       Date:  1995-11       Impact factor: 3.441

Review 3.  Antifungal peptides: novel therapeutic compounds against emerging pathogens.

Authors:  A J De Lucca; T J Walsh
Journal:  Antimicrob Agents Chemother       Date:  1999-01       Impact factor: 5.191

4.  Antimicrobial activities of squalamine mimics.

Authors:  K Kikuchi; E M Bernard; A Sadownik; S L Regen; D Armstrong
Journal:  Antimicrob Agents Chemother       Date:  1997-07       Impact factor: 5.191

5.  The Pepsin Hydrolysate of Bovine Lactoferrin Causes a Collapse of the Membrane Potential in Escherichia coli O157:H7.

Authors:  Christopher Murdock; Michael L Chikindas; Karl R Matthews
Journal:  Probiotics Antimicrob Proteins       Date:  2010-06       Impact factor: 4.609

6.  Activity of novispirin G10 against Pseudomonas aeruginosa in vitro and in infected burns.

Authors:  Lars Steinstraesser; Brian F Tack; Alan J Waring; Teresa Hong; Lee M Boo; Ming-Hui Fan; Daniel I Remick; Grace L Su; Robert I Lehrer; Stewart C Wang
Journal:  Antimicrob Agents Chemother       Date:  2002-06       Impact factor: 5.191

7.  Peptide-based Antifungal Therapies against Emerging Infections.

Authors:  A Matejuk; Q Leng; M D Begum; M C Woodle; P Scaria; S-T Chou; A J Mixson
Journal:  Drugs Future       Date:  2010-03       Impact factor: 0.148

8.  Different anti-Candida activities of two human lactoferrin-derived peptides, Lfpep and kaliocin-1.

Authors:  Mónica Viejo-Díaz; María T Andrés; José F Fierro
Journal:  Antimicrob Agents Chemother       Date:  2005-07       Impact factor: 5.191

9.  Effect of lactoferricin B, a pepsin-generated peptide of bovine lactoferrin, on Escherichia coli HB101 (pRI203) entry into HeLa cells.

Authors:  C Longhi; M P Conte; W Bellamy; L Seganti; P Valenti
Journal:  Med Microbiol Immunol       Date:  1994-05       Impact factor: 3.402

Review 10.  Human milk glycoproteins protect infants against human pathogens.

Authors:  Bo Liu; David S Newburg
Journal:  Breastfeed Med       Date:  2013-05-22       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.